We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ranbaxy Suspends Generic Lipitor Manufacturing Following Recall
Ranbaxy Suspends Generic Lipitor Manufacturing Following Recall
January 8, 2013
Ranbaxy has temporarily ceased production of generic Lipitor while it investigates and remediates the cause of glass particulate contamination that spurred a 41-lot recall last November, the FDA said.